According to a new study conducted by the University of Manchester and East Anglia, in people with rheumatoid arthritis after an early and intensive treatment condition improves.
Gvinnatt James, author of the University of Manchester, conducted a study on arthritis in the UK, which included data for 20 years, from 1990 to 2010. These 602 participants in the study, published in the journal Arthritis and Rheumatology, were included in the register of arthritis Norfolk and evaluated at regular intervals for 20 years.
Scientists have found that patients who are within six months after the onset of symptoms to prescribe drugs that modify sulfasalazine, methotrexate and steroids, went, stayed and dressed much better compared with patients who were prescribed treatment later. In patients receiving drug therapy in the first 6 months, after controlling for the severity of the disease had a lower risk of mortality.
According Gvinnatta, the study shows that in patients who have just received treatment after the detection of symptoms were similar levels of disability over the next 20 years compared to patients who, in the opinion of clinicians do not need treatment after accounting for differences in disease severity between groups.
"Although there is a wide range in terms of how people experience the disease, the number of patients whose state of health has improved, has increased due to the timely treatment. The good news is that early intervention has become increasingly common over the past 20 years - added Gvinnatt. - In the early 1990s, early treatment was used in 30% of cases. Today, the figure is 60-70%. And further figures will only grow. "
Dr. Natalie Carter, Head of Research and Evaluation at the Center for Arthritis Research UK, said: "Rheumatoid arthritis - a painful condition that can be diagnosed at any age. The work confirms the importance of early diagnosis and initiation of treatment. Nice to hear the progress made in 20 years. Now, the scientific community needs to continue to achieve positive results and make the daily lives of patients easier. "
Rheumatoid arthritis - an autoimmune disease that causes inflammation of the joints, causing pain there. This second common form of arthritis in the United Kingdom, which affects 1% of adults. Over the past 20 years has made significant progress in the available therapies and disease management strategies.